Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2000
12/28/2000WO2000078319A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000WO2000078318A1 Medicinal composition for oral administration
12/28/2000WO2000078145A1 Macrophage scavenger receptor antagonists
12/28/2000WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands
12/28/2000WO2000048625A3 Inhibitors for use in hemostasis and immune function
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
12/28/2000DE19917705C1 Mittel zur Therapie von Hyperphosphatämie Means for therapy of hyperphosphatemia
12/28/2000CA2378051A1 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood
12/28/2000CA2377698A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000CA2377288A1 Macrophage scavenger receptor antagonists
12/28/2000CA2376155A1 Pharmaceutical composition for oral use
12/28/2000CA2375527A1 Method for enhancing hematopoiesis
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375396A1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
12/28/2000CA2375268A1 Indoloazepines as vasopressin receptor antagonists
12/28/2000CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses
12/27/2000EP1063235A1 Benzofurylpyrone derivatives
12/27/2000EP1063230A1 Cyclic amino compounds
12/27/2000EP1062236A1 31 human secreted proteins
12/27/2000EP1062224A1 Modified factor viii
12/27/2000EP1062222A1 Serine peptidase modulators
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1062204A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1061937A1 Improved radiation therapy methods
12/27/2000EP1061934A1 Fibrinogen receptor antagonists
12/27/2000EP1061931A2 Thrombin preparation and products and fibrin sealant methods employing same
12/27/2000EP1061930A1 Supercritical conditioned gas mixture containing co 2?, no and optionally a neutral gas
12/27/2000EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
12/27/2000EP1061812A1 Food products having enhanced cocoa polyphenol content and processes for producing same
12/27/2000EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2000CN1278263A 2,3-diaryl-pyrazolo [1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2 (cox-2) inhibitors
12/27/2000CN1278180A Method for treating hypercholesterolemia by using unsubstituted polydiallylamine
12/27/2000CN1277961A Novel 2,3-methylene amino acid compound, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1059827C Complex ferrous sulfate tablet
12/26/2000US6166088 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
12/26/2000US6166055 Antiinflammatory agents
12/26/2000US6166022 Treatment of platelet aggregation disorders and angina
12/26/2000US6166014 Treatment of disease-states characterized by thrombotic activity
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165974 Administering an effective dose of a pharmaceutical preparation comprising at least two coagulation factors which are components of a prothrombinase or of a pro-prothrombinase to the patient for the treatment of acute bleeding
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077246A2 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077233A2 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077221A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077028A1 Retro-inverso peptides derived from interleukin-3
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000076998A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076556A2 High dose radionuclide complexes for bone marrow suppression
12/21/2000WO2000076536A1 Use of adenosine to minimize reperfusion injury
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076504A1 Production of agglomerates of inogatran and the compound inogatran anhydrate
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076501A1 Il-8 receptor antagonists
12/21/2000WO2000076495A1 Il-8 receptor antagonists
12/21/2000WO2000076451A2 Pharmaceutical composition comprising no or at least a no donor compound inducing no formation in cells
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000WO2000044366A3 Therapeutic compositions containing glutathione analogs
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2377395A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377386A1 Il-8 receptor antagonists
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376467A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376394A1 Retro-inverso peptides derived from interleukin-3
12/21/2000CA2376302A1 Pharmaceutical composition comprising no or at least a no donor compound or another compound capable of releasing or inducing no fromation in cells
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/20/2000EP1060747A2 Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
12/20/2000EP1060242A1 Purified populations of stem cells
12/20/2000EP1060166A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059889A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor
12/20/2000EP1015089A4 Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent
1 ... 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 ... 671